Novo Integrated Sciences, Inc. (NVOS)
USD 0.0
(42.86%)
USD 0.0
(42.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.05 Million USD | -62.51% |
| 2022 | 10.81 Million USD | 99.75% |
| 2021 | 5.41 Million USD | 132.76% |
| 2020 | 2.32 Million USD | 9.42% |
| 2019 | 2.12 Million USD | 128.47% |
| 2018 | 930.64 Thousand USD | -74.47% |
| 2017 | 3.64 Million USD | -46.57% |
| 2016 | 6.82 Million USD | 8.0% |
| 2015 | 6.31 Million USD | 1111.87% |
| 2014 | 521.21 Thousand USD | 3.83% |
| 2013 | 502.01 Thousand USD | 432.33% |
| 2012 | 94.3 Thousand USD | 2212.53% |
| 2011 | 4078.00 USD | 103.18% |
| 2010 | -128.26 Thousand USD | 78.75% |
| 2009 | -603.51 Thousand USD | -1395.12% |
| 2008 | 46.59 Thousand USD | 1751.28% |
| 2007 | -2822.00 USD | -160.81% |
| 2006 | -1082.00 USD | 91.98% |
| 2005 | -13.48 Thousand USD | -105.35% |
| 2004 | 251.87 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.96 Million USD | -36.85% |
| 2024 Q1 | 3 Million USD | -26.0% |
| 2024 Q2 | 4.69 Million USD | 56.28% |
| 2023 Q2 | 3.72 Million USD | -61.1% |
| 2023 Q1 | 9.58 Million USD | -11.37% |
| 2023 FY | 4.05 Million USD | -62.51% |
| 2023 Q3 | 4.11 Million USD | 10.3% |
| 2023 Q4 | 4.05 Million USD | -1.41% |
| 2022 Q2 | 4.66 Million USD | -24.5% |
| 2022 Q4 | 10.81 Million USD | 25.63% |
| 2022 FY | 10.81 Million USD | 99.75% |
| 2022 Q1 | 6.18 Million USD | 14.17% |
| 2022 Q3 | 8.61 Million USD | 84.47% |
| 2021 FY | 5.41 Million USD | 132.76% |
| 2021 Q3 | -4.64 Million USD | -292.91% |
| 2021 Q4 | 5.41 Million USD | 216.67% |
| 2021 Q1 | 1.76 Million USD | -24.25% |
| 2021 Q2 | 2.4 Million USD | 36.53% |
| 2020 Q2 | 3.01 Million USD | 38.85% |
| 2020 Q4 | 2.32 Million USD | -12.69% |
| 2020 FY | 2.32 Million USD | 9.42% |
| 2020 Q3 | 2.66 Million USD | -11.55% |
| 2020 Q1 | 2.16 Million USD | 2.04% |
| 2019 FY | 2.12 Million USD | 128.47% |
| 2019 Q1 | 652 Thousand USD | -29.94% |
| 2019 Q2 | -778.29 Thousand USD | -219.37% |
| 2019 Q3 | 1.27 Million USD | 264.31% |
| 2019 Q4 | 2.12 Million USD | 66.27% |
| 2018 Q4 | 930.64 Thousand USD | 19.84% |
| 2018 Q3 | 776.57 Thousand USD | 24.43% |
| 2018 Q2 | 624.08 Thousand USD | -84.71% |
| 2018 Q1 | 4.08 Million USD | 11.98% |
| 2018 FY | 930.64 Thousand USD | -74.47% |
| 2017 Q1 | -54.35 Thousand USD | -100.79% |
| 2017 Q4 | 3.64 Million USD | 4.96% |
| 2017 Q3 | 3.47 Million USD | -46.81% |
| 2017 Q2 | 6.52 Million USD | 12113.81% |
| 2017 FY | 3.64 Million USD | -46.57% |
| 2016 FY | 6.82 Million USD | 8.0% |
| 2016 Q2 | -33.5 Thousand USD | -137.22% |
| 2016 Q3 | -17.46 Thousand USD | 47.88% |
| 2016 Q4 | 6.86 Million USD | 39403.62% |
| 2016 Q1 | -14.12 Thousand USD | -61.74% |
| 2015 FY | 6.31 Million USD | 1111.87% |
| 2015 Q3 | -8271.00 USD | 5.15% |
| 2015 Q1 | 521.21 Thousand USD | 3.93% |
| 2015 Q2 | -8720.00 USD | -101.67% |
| 2015 Q4 | -8732.00 USD | -5.57% |
| 2014 FY | 521.21 Thousand USD | 3.83% |
| 2014 Q3 | 481.71 Thousand USD | 17.65% |
| 2014 Q1 | 502.01 Thousand USD | 5.29% |
| 2014 Q4 | 501.52 Thousand USD | 4.11% |
| 2014 Q2 | 409.44 Thousand USD | -18.44% |
| 2013 FY | 502.01 Thousand USD | 432.33% |
| 2013 Q4 | 476.78 Thousand USD | 655.0% |
| 2013 Q3 | 63.15 Thousand USD | -16.28% |
| 2013 Q2 | 75.42 Thousand USD | -20.02% |
| 2013 Q1 | 94.3 Thousand USD | 103.47% |
| 2012 Q4 | 46.34 Thousand USD | 437.5% |
| 2012 Q2 | 15.97 Thousand USD | 291.83% |
| 2012 Q1 | 4078.00 USD | 150.32% |
| 2012 FY | 94.3 Thousand USD | 2212.53% |
| 2012 Q3 | 8623.00 USD | -46.04% |
| 2011 Q4 | -8104.00 USD | -67.3% |
| 2011 Q2 | -62.1 Thousand USD | 51.58% |
| 2011 Q1 | -128.26 Thousand USD | 59.08% |
| 2011 Q3 | -4844.00 USD | 92.2% |
| 2011 FY | 4078.00 USD | 103.18% |
| 2010 Q1 | -603.51 Thousand USD | -126.31% |
| 2010 FY | -128.26 Thousand USD | 78.75% |
| 2010 Q4 | -313.41 Thousand USD | -4.29% |
| 2010 Q3 | -300.51 Thousand USD | 61.37% |
| 2010 Q2 | -777.85 Thousand USD | -28.89% |
| 2009 Q4 | -266.67 Thousand USD | -423.63% |
| 2009 FY | -603.51 Thousand USD | -1395.12% |
| 2009 Q1 | 46.59 Thousand USD | 41.78% |
| 2009 Q2 | -13.91 Thousand USD | -129.87% |
| 2009 Q3 | -50.92 Thousand USD | -265.91% |
| 2008 Q4 | 32.86 Thousand USD | 12.15% |
| 2008 Q1 | -2822.00 USD | 94.53% |
| 2008 Q2 | 952.00 USD | 133.73% |
| 2008 FY | 46.59 Thousand USD | 1751.28% |
| 2008 Q3 | 29.3 Thousand USD | 2978.47% |
| 2007 Q2 | -64.73 Thousand USD | -5883.09% |
| 2007 Q4 | -51.62 Thousand USD | -1837.84% |
| 2007 Q1 | -1082.00 USD | 90.47% |
| 2007 Q3 | -2664.00 USD | 95.88% |
| 2007 FY | -2822.00 USD | -160.81% |
| 2006 FY | -1082.00 USD | 91.98% |
| 2006 Q4 | -11.35 Thousand USD | 52.18% |
| 2006 Q3 | -23.74 Thousand USD | -3917.2% |
| 2006 Q2 | 622.00 USD | 104.61% |
| 2006 Q1 | -13.48 Thousand USD | -4751.44% |
| 2005 FY | -13.48 Thousand USD | -105.35% |
| 2005 Q2 | -1189.00 USD | 0.0% |
| 2005 Q3 | -12.5 Thousand USD | -951.3% |
| 2005 Q4 | -278.00 USD | 97.78% |
| 2004 FY | 251.87 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 99.713% |
| Addus HomeCare Corporation | 110.39 Million USD | 96.326% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 95.464% |
| Amedisys, Inc. | 341.35 Million USD | 98.812% |
| American Oncology Network, Inc. | 99.78 Million USD | 95.936% |
| Astrana Health, Inc. | 27.2 Million USD | 85.095% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 99.721% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 1930.756% |
| biote Corp. | 25.86 Million USD | 84.324% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 61.341% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 134.289% |
| COMPASS Pathways plc | -187.58 Million USD | 102.162% |
| DocGo Inc. | -12.78 Million USD | 131.709% |
| The Ensign Group, Inc. | 1.36 Billion USD | 99.702% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 137.918% |
| InnovAge Holding Corp. | 56.08 Million USD | 92.77% |
| Assure Holdings Corp. | 14.68 Million USD | 72.379% |
| The Joint Corp. | -2.47 Million USD | 263.557% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 99.062% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 167.024% |
| ModivCare Inc. | 1.13 Billion USD | 99.643% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -1356.398% |
| Option Care Health, Inc. | 822.56 Million USD | 99.507% |
| P3 Health Partners Inc. | 83.7 Million USD | 95.155% |
| P3 Health Partners Inc. | 83.7 Million USD | 95.155% |
| The Pennant Group, Inc. | 323.57 Million USD | 98.747% |
| Surgery Partners, Inc. | 2.86 Billion USD | 99.858% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 233.752% |
| Talkspace, Inc. | -123.9 Million USD | 103.273% |
| Talkspace, Inc. | -123.9 Million USD | 103.273% |
| The Oncology Institute, Inc. | 86.32 Million USD | 95.302% |
| The Oncology Institute, Inc. | 86.32 Million USD | 95.302% |